We are Sorry, This Page doesn't Exist
Vertex completes enrollment of two Phase 3 studies of cystic fibrosis candidate
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
A Peninsula cell therapy company"s shares plunged 39% after its CEO resigned and the FDA raised manufacturing questions
Fardis had guided Iovance from being a little-know startup to the cusp of having an approved treatment. But the FDA request will set back its approval process by two years......»»
Arrowhead announces improvement in fibrosis after ARO-AAT treatment in Patients
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vertex Pharmaceuticals announces EC approval for Kaftrio label extension
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vertex to study experimental gene-editing therapy as treatment for sickle cell, beta-thalassemia
Vertex Pharmaceuticals Inc. said Tuesday it plans to pay $1.1 billion to Crispr Therapeutics AG as part of a deal to test an experimental gene-editing therapy for sickle cell disease and transfusion-dependent beta-tha.....»»
NovoCure surges 65% to all-time high on upbeat review of its lung cancer treatment trial
"Pending regulatory approval, the recommended protocol adjustments could accelerate trial completion by more than a year," its CEO said. In this phot.....»»
Syndax treatment of idiopathic pulmonary fibrosis granted FDA orphan status
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
United Therapeutics gets another FDA approval for pulmonary hypertension therapy
United Therapeutics (NASDAQ: UTHR) has received another Food and Drug Administration approval for Tyvaso more than a decade after the agency first approved the therapy for treatment of pulmonary arterial hypertension. The FDA approved a supplem.....»»
Vertex receives Australian G approval for TRIKAFTA
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Translate Bio Shares Drop After Its mRNA-Based Cystic Fibrosis Candidate Did Not Improve Lung Function
Translate Bio Inc (NASDAQ: TBIO) revealed its second interim analysis from Phase 1/2 clinical trial evaluating MRT5005 in patients with cystic fibrosis (CF). Latest Ratings f.....»»
Vertex to begin Phase 1/2 trial of treatment for people with type 1 diabetes
Shares of Vertex Pharmaceuticals Inc. were down 0.2% in trading on Wednesday after the company said it started an early-stage clinical t.....»»
Sarepta rallies 2% to $86.15 after winning FDA approval for DMD treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Beyond Air receives grant for up to $2.17M from the Cystic Fibrosis Foundation
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Eloxx Pharmaceuticals" ELX-02 featured in Journal of Cystic Fibrosis
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Durect stock soars 34% after it gets FDA approval for surgical pain treatment
Shares of Durect Corp. gained 34.3% in premarket trading on Tuesday after the company said its drug,.....»»
FDA posts approval of Durect pain treatment Posimir
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Why AzurRx BioPharma Is Trading Sharply Higher Today
AzurRx BioPharma (NASDAQ: AZRX) shares are trading higher Friday amid a surge in session volume for the day. On Thursday, the company announced it has started dosing in the mid-stage cystic fibrosis study of MS1819. read more.....»»
The best acne treatments for every type of skin, according to dermatologists
The type of acne treatment you use has everything to do with the type of acne you have. We spoke to dermatologists about the best way to treat various types of acne, from blackheads to cystic bumps. There.....»»
Sumitovant unit Urovant gets FDA approval of Gemtesa NDA for OAB treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»